SENSEX: 72,400 ▲ 0.5% NIFTY: 21,800 ▲ 0.4% GOLD: 62,500 ▼ 0.2%

Pharmaceutical APIs

Divi’s Laboratories Reports Steady Q3 FY26 Growth Amid Labour Code Impact

● Feb 11, 2026

Divi’s Laboratories Limited (NSE: DIVISLAB), a leading Indian API manufacturer, posted consolidated total income of INR 2,692 crores for Q3...

● Feb 10, 2026

Aarti Pharmalabs Limited (NSE: AARTIPHARM, BSE: 543748) reported a sequential improvement in operating performance in the quarter ended Dec. 31,...

Market Headlines

Get the latest market analysis delivered to your inbox.